Morgan Stanley Revolution Medicines, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Morgan Stanley holds 652,818 shares of RVMD stock, worth $28.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

652,818

Previous 995,489 34.42%

Holding current value

$28.8 Million

Previous $38.6 Million 23.44%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$36.92 - $47.94 $12.7 Million - $16.4 Million	-342,671 Reduced 34.42%	652,818 $29.6 Million
Q2 2024 Oct 17, 2024	BUY	$30.14 - $40.68 $2.06 Million - $2.78 Million	68,419 Added 7.38%	995,489 $38.6 Million
Q2 2024 Aug 14, 2024	BUY	$30.14 - $40.68 $2.06 Million - $2.78 Million	68,419 Added 7.38%	995,489 $38.6 Million
Q1 2024 Oct 17, 2024	SELL	$26.56 - $33.55 $1.82 Million - $2.3 Million	-68,419 Reduced 6.87%	927,070 $29.9 Million
Q1 2024 Aug 16, 2024	SELL	$26.56 - $33.55 $19.3 Million - $24.4 Million	-726,104 Reduced 43.92%	927,070 $29.9 Million
Q1 2024 May 15, 2024	SELL	$26.56 - $33.55 $19.3 Million - $24.4 Million	-726,104 Reduced 43.92%	927,070 $29.9 Million
Q4 2023 Aug 16, 2024	BUY	$18.35 - $34.12 $12.1 Million - $22.4 Million	657,685 Added 66.07%	1,653,174 $47.4 Million
Q4 2023 Feb 13, 2024	BUY	$18.35 - $34.12 $15.6 Million - $29 Million	851,201 Added 106.14%	1,653,174 $47.4 Million
Q3 2023 Nov 15, 2023	SELL	$25.17 - $35.05 $4.57 Million - $6.36 Million	-181,522 Reduced 18.46%	801,973 $22.2 Million
Q2 2023 Aug 14, 2023	BUY	$20.28 - $27.0 $12.1 Million - $16.2 Million	598,758 Added 155.63%	983,495 $26.3 Million
Q1 2023 May 15, 2023	BUY	$20.76 - $30.09 $970,758 - $1.41 Million	46,761 Added 13.84%	384,737 $8.33 Million
Q4 2022 Feb 14, 2023	BUY	$17.68 - $25.53 $1.52 Million - $2.2 Million	86,212 Added 34.24%	337,976 $8.05 Million
Q3 2022 Nov 14, 2022	BUY	$17.46 - $26.0 $169,955 - $253,084	9,734 Added 4.02%	251,764 $4.96 Million
Q2 2022 Oct 27, 2022	BUY	$14.54 - $27.17 $788,954 - $1.47 Million	54,261 Added 28.9%	242,030 $4.72 Million
Q2 2022 Aug 15, 2022	BUY	$14.54 - $27.17 $788,954 - $1.47 Million	54,261 Added 28.9%	242,030 $4.72 Million
Q1 2022 Oct 27, 2022	SELL	$17.31 - $26.4 $939,257 - $1.43 Million	-54,261 Reduced 22.42%	187,769 $4.79 Million
Q1 2022 May 13, 2022	BUY	$17.31 - $26.4 $2.4 Million - $3.67 Million	138,843 Added 283.78%	187,769 $4.79 Million
Q4 2021 Feb 14, 2022	SELL	$24.35 - $33.7 $1.24 Million - $1.72 Million	-51,057 Reduced 51.07%	48,926 $1.23 Million
Q3 2021 Nov 15, 2021	BUY	$23.95 - $33.41 $2.39 Million - $3.34 Million	99,983 New	99,983 $2.75 Million

Others Institutions Holding RVMD

# of Institutions

266

Shares Held

161M

Call Options Held

260K

Put Options Held

620K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.86B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account